Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

por Motzer, Robert J., Escudier, Bernard, Powles, Thomas, Scheffold, Christian, Choueiri, Toni K.
Publicado 2018

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape

por Gulati, Shuchi, Labaki, Chris, Karachaliou, Georgia Sofia, Choueiri, Toni K, Zhang, Tian
Publicado 2022

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer

por Yekedüz, Emre, McKay, Rana R, Gillessen, Silke, Choueiri, Toni K, Ürün, Yüksel
Publicado 2023

Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1

por Chakraborty, Samik, Balan, Murugabaskar, Flynn, Evelyn, Zurakowski, David, Choueiri, Toni K., Pal, Soumitro
Publicado 2019

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

por Fay, Andre P., McKay, Rana R., Lin, Xun, Simantov, Ronit, Choueiri, Toni K.
Publicado 2018

In Reply

por de Velasco, Guillermo, Culhane, Aedín C., Heng, Daniel Y.C., Signoretti, Sabina, Choueiri, Toni K.
Publicado 2017

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

por Rubinstein, Samuel M., Steinharter, John A., Warner, Jeremy, Rini, Brian I., Peters, Solange, Choueiri, Toni K.
Publicado 2020

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

por Labaki, Chris, Bakouny, Ziad, Schmidt, Andrew, Lipsitz, Stuart R., Rebbeck, Timothy R., Trinh, Quoc-Dien, Choueiri, Toni K.
Publicado 2021

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma

por Mullane, Stephanie A., Werner, Lillian, Rosenberg, Jonathan, Signoretti, Sabina, Callea, Marcella, Choueiri, Toni K., Freeman, Gordon J., Bellmunt, Joaquim
Publicado 2016

COVID-19 and Cancer: Current Challenges and Perspectives

por Bakouny, Ziad, Hawley, Jessica E., Choueiri, Toni K., Peters, Solange, Rini, Brian I., Warner, Jeremy L., Painter, Corrie A.
Publicado 2020

Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors

por Park, Hyo Jung, Qin, Lei, Bakouny, Ziad, Krajewski, Katherine M, Van Allen, Eliezer M, Choueiri, Toni K, Shinagare, Atul B
Publicado 2022

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma

por Marmarelis, Melina E., Davis, Meredith R., Sethi, Nilay S., Krajewksi, Katherine M., McKay, Rana R., Choueiri, Toni K., Ott, Patrick A.
Publicado 2016

Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset

por Kehl, Kenneth L., Xu, Wenxin, Gusev, Alexander, Bakouny, Ziad, Choueiri, Toni K., Riaz, Irbaz Bin, Elmarakeby, Haitham, Van Allen, Eliezer M., Schrag, Deborah
Publicado 2021

Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system

por Sun, Maxine, Karakiewicz, Pierre I, Sammon, Jesse D, Sukumar, Shyam, Gervais, Mai-Kim, Nguyen, Paul L, Choueiri, Toni K, Menon, Mani, Trinh, Quoc-Dien
Publicado 2014

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series

por Martini, Dylan J., Lalani, Aly-Khan A., Bossé, Dominick, Steinharter, John A., Harshman, Lauren C., Hodi, F. Stephen, Ott, Patrick A., Choueiri, Toni K.
Publicado 2017

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma

por Atkins, Michael B, Gupta, Shilpa, Choueiri, Toni K, McDermott, David F, Puzanov, Igor, Tarazi, Jamal, Keefe, Stephen, Rosbrook, Brad, Chakrabarti, Debasis, Plimack, Elizabeth R
Publicado 2015

Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC

por Ross-Macdonald, Petra, Walsh, Alice M, Chasalow, Scott D, Ammar, Ron, Papillon-Cavanagh, Simon, Szabo, Peter M, Choueiri, Toni K, Sznol, Mario, Wind-Rotolo, Megan
Publicado 2021

Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy

por Choueiri, Toni K, Porta, Camillo, Suárez, Cristina, Hainsworth, John, Voog, Eric, Duran, Ignacio, Reeves, James, Czaykowski, Piotr, Castellano, Daniel, Chen, Jingjing, Sedarati, Farhad, Powles, Thomas
Publicado 2022

Quality‐adjusted survival with first‐line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)

por Chen, Ronald C., Choueiri, Toni K., Feuilly, Marion, Meng, Jie, Lister, Johanna, Marteau, Florence, Falchook, Aaron D., Morris, Michael J., George, Daniel J., Feldman, Darren R.
Publicado 2020

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States

por Seisen, Thomas, Labban, Muhieddine, Lipsitz, Stuart R., Preston, Mark A., Mossanen, Matthew, Bellmunt, Joaquim, Rouprêt, Morgan, Choueiri, Toni K., Kibel, Adam S., Sun, Maxine, Trinh, Quoc-Dien
Publicado 2023